These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 22782111)

  • 1. Monoamine oxidases in development.
    Wang CC; Billett E; Borchert A; Kuhn H; Ufer C
    Cell Mol Life Sci; 2013 Feb; 70(4):599-630. PubMed ID: 22782111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitor design for monoamine oxidases.
    Ramsay RR
    Curr Pharm Des; 2013; 19(14):2529-39. PubMed ID: 23116392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective MAO-B inhibitors: a lesson from natural products.
    Carradori S; D'Ascenzio M; Chimenti P; Secci D; Bolasco A
    Mol Divers; 2014 Feb; 18(1):219-43. PubMed ID: 24218136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin receptor 6 mediates defective brain development in monoamine oxidase A-deficient mouse embryos.
    Wang CC; Man GC; Chu CY; Borchert A; Ugun-Klusek A; Billett EE; Kühn H; Ufer C
    J Biol Chem; 2014 Mar; 289(12):8252-63. PubMed ID: 24497636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoamine Oxidase Inhibitors: From Classic to New Clinical Approaches.
    Duarte P; Cuadrado A; León R
    Handb Exp Pharmacol; 2021; 264():229-259. PubMed ID: 32852645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of monoamine oxidase in zebrafish (Danio rerio).
    Setini A; Pierucci F; Senatori O; Nicotra A
    Comp Biochem Physiol B Biochem Mol Biol; 2005 Jan; 140(1):153-61. PubMed ID: 15621520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive review of monoamine oxidase inhibitors as Anti-Alzheimer's disease agents: A review.
    Manzoor S; Hoda N
    Eur J Med Chem; 2020 Nov; 206():112787. PubMed ID: 32942081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinolinyl-thienyl chalcones as monoamine oxidase inhibitors and their in silico modeling studies.
    Zaib S; Rizvi SU; Aslam S; Ahmad M; Ali Abid SM; Al-Rashida M; Iqbal J
    Med Chem; 2015; 11(6):580-9. PubMed ID: 25541744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characteristics of a single and novel form of carp (Cyprinus carpio) monoamine oxidase.
    Sugimoto H; Taguchi YD; Shibata K; Kinemuchi H
    Comp Biochem Physiol B Biochem Mol Biol; 2010 Mar; 155(3):266-71. PubMed ID: 19932189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromone 3-phenylcarboxamides as potent and selective MAO-B inhibitors.
    Gaspar A; Reis J; Fonseca A; Milhazes N; Viña D; Uriarte E; Borges F
    Bioorg Med Chem Lett; 2011 Jan; 21(2):707-9. PubMed ID: 21194943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human monoamine oxidase A and B by flavonoids isolated from two Algerian medicinal plants.
    Larit F; Elokely KM; Chaurasiya ND; Benyahia S; Nael MA; León F; Abu-Darwish MS; Efferth T; Wang YH; Belouahem-Abed D; Benayache S; Tekwani BL; Cutler SJ
    Phytomedicine; 2018 Feb; 40():27-36. PubMed ID: 29496172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoamine oxidase inactivation: from pathophysiology to therapeutics.
    Bortolato M; Chen K; Shih JC
    Adv Drug Deliv Rev; 2008; 60(13-14):1527-33. PubMed ID: 18652859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibiting Monoamine Oxidase in CNS and CVS would be a Promising Approach to Mitigating Cardiovascular Complications in Neurodegenerative Disorders.
    Srivastava P; Sudevan ST; Thennavan A; Mathew B; Kanthlal SK
    CNS Neurol Disord Drug Targets; 2024; 23(3):331-341. PubMed ID: 36872357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substrate and inhibitor specificities for human monoamine oxidase A and B are influenced by a single amino acid.
    Geha RM; Rebrin I; Chen K; Shih JC
    J Biol Chem; 2001 Mar; 276(13):9877-82. PubMed ID: 11134050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging role of monoamine oxidase as a therapeutic target for cardiovascular disease.
    Deshwal S; Di Sante M; Di Lisa F; Kaludercic N
    Curr Opin Pharmacol; 2017 Apr; 33():64-69. PubMed ID: 28528298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benextramine and derivatives as novel human monoamine oxidases inhibitors: an integrated approach.
    Di Paolo ML; Cozza G; Milelli A; Zonta F; Sarno S; Minniti E; Ursini F; Rosini M; Minarini A
    FEBS J; 2019 Dec; 286(24):4995-5015. PubMed ID: 31291696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoamine Oxidase (MAO) as a Potential Target for Anticancer Drug Design and Development.
    Aljanabi R; Alsous L; Sabbah DA; Gul HI; Gul M; Bardaweel SK
    Molecules; 2021 Oct; 26(19):. PubMed ID: 34641563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural comparison of human monoamine oxidases A and B: mass spectrometry monitoring of cysteine reactivities.
    Hubalek F; Pohl J; Edmondson DE
    J Biol Chem; 2003 Aug; 278(31):28612-8. PubMed ID: 12777388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoamine oxidase a expression is vital for embryonic brain development by modulating developmental apoptosis.
    Wang CC; Borchert A; Ugun-Klusek A; Tang LY; Lui WT; Chu CY; Billett E; Kuhn H; Ufer C
    J Biol Chem; 2011 Aug; 286(32):28322-30. PubMed ID: 21697081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a region important for human monoamine oxidase B substrate and inhibitor selectivity.
    Grimsby J; Zentner M; Shih JC
    Life Sci; 1996; 58(9):777-87. PubMed ID: 8632725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.